Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Sluggishness of Early-Stage Face Processing (N170) Is Correlated with Negative and General Psychiatric Symptoms in Schizophrenia.

Zheng Y, Li H, Ning Y, Ren J, Wu Z, Huang R, Luan G, Li T, Bi T, Wang Q, She S.

Front Hum Neurosci. 2016 Nov 28;10:615. eCollection 2016.

2.

Cognitive Enhancement Therapy Improves Resting-State Functional Connectivity in Early Course Schizophrenia.

Eack SM, Newhill CE, Keshavan MS.

J Soc Social Work Res. 2016 Summer;7(2):211-230. Epub 2016 May 2.

PMID:
27713804
3.

Progressive deterioration of thalamic nuclei relates to cortical network decline in schizophrenia.

Cobia DJ, Smith MJ, Salinas I, Ng C, Gado M, Csernansky JG, Wang L.

Schizophr Res. 2017 Feb;180:21-27. doi: 10.1016/j.schres.2016.08.003. Epub 2016 Sep 7.

PMID:
27613507
4.

Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review.

Crespo-Facorro B, Pelayo-Teran JM, Mayoral-van Son J.

Neurol Ther. 2016 Dec;5(2):105-130. Epub 2016 Aug 23. Review.

5.

Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.

Torres US, Duran FL, Schaufelberger MS, Crippa JA, Louzã MR, Sallet PC, Kanegusuku CY, Elkis H, Gattaz WF, Bassitt DP, Zuardi AW, Hallak JE, Leite CC, Castro CC, Santos AC, Murray RM, Busatto GF.

Neuroimage Clin. 2016 Jun 3;12:1-15. doi: 10.1016/j.nicl.2016.06.002. eCollection 2016.

6.

Dynamic endophenotypes and longitudinal trajectories: capturing changing aspects of development in early psychosis.

Shah JL, Chakravarty MM, Joober R, Lepage M.

J Psychiatry Neurosci. 2016 Apr;41(3):148-51. No abstract available.

7.

Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

Notarangelo FM, Pocivavsek A.

Neuropharmacology. 2017 Jan;112(Pt B):275-285. doi: 10.1016/j.neuropharm.2016.03.001. Epub 2016 Mar 2. Review.

PMID:
26944732
8.

Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function.

Guo JY, Huhtaniska S, Miettunen J, Jääskeläinen E, Kiviniemi V, Nikkinen J, Moilanen J, Haapea M, Mäki P, Jones PB, Veijola J, Isohanni M, Murray GK.

Schizophr Res. 2015 Oct;168(1-2):297-304. doi: 10.1016/j.schres.2015.06.016. Epub 2015 Jul 16.

9.

Neuropsychology, autobiographical memory, and hippocampal volume in "younger" and "older" patients with chronic schizophrenia.

Herold CJ, Lässer MM, Schmid LA, Seidl U, Kong L, Fellhauer I, Thomann PA, Essig M, Schröder J.

Front Psychiatry. 2015 Apr 21;6:53. doi: 10.3389/fpsyt.2015.00053. eCollection 2015.

10.

Obsessive-Compulsive Disorder, Psychosis, and Bipolarity: A Longitudinal Cohort and Multigenerational Family Study.

Cederlöf M, Lichtenstein P, Larsson H, Boman M, Rück C, Landén M, Mataix-Cols D.

Schizophr Bull. 2015 Sep;41(5):1076-83. doi: 10.1093/schbul/sbu169. Epub 2014 Dec 15.

11.

Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.

Pershing ML, Bortz DM, Pocivavsek A, Fredericks PJ, Jørgensen CV, Vunck SA, Leuner B, Schwarcz R, Bruno JP.

Neuropharmacology. 2015 Mar;90:33-41. doi: 10.1016/j.neuropharm.2014.10.017. Epub 2014 Nov 1.

12.

Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats.

Pocivavsek A, Thomas MA, Elmer GI, Bruno JP, Schwarcz R.

Psychopharmacology (Berl). 2014 Jul;231(14):2799-809. doi: 10.1007/s00213-014-3452-2. Epub 2014 Mar 4.

13.
14.

A family affair: brain abnormalities in siblings of patients with schizophrenia.

Moran ME, Hulshoff Pol H, Gogtay N.

Brain. 2013 Nov;136(Pt 11):3215-26. doi: 10.1093/brain/awt116. Epub 2013 May 22. Review.

15.

The myth of schizophrenia as a progressive brain disease.

Zipursky RB, Reilly TJ, Murray RM.

Schizophr Bull. 2013 Nov;39(6):1363-72. doi: 10.1093/schbul/sbs135. Epub 2012 Nov 20. Review.

16.

Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia.

Francis AN, Seidman LJ, Jabbar GA, Mesholam-Gately R, Thermenos HW, Juelich R, Proal AC, Shenton M, Kubicki M, Mathew I, Keshavan M, Delisi LE.

Schizophr Res. 2012 Oct;141(1):65-71. doi: 10.1016/j.schres.2012.07.015. Epub 2012 Aug 11.

17.

Schizophernia and empty sella - casual or correlated?

Wix-Ramos RJ, Capote E, Mendoza M, Garcia M, Ezequiel U.

Pol J Radiol. 2011 Apr;76(2):49-51.

18.

A framework for interpreting functional networks in schizophrenia.

Williamson PC, Allman JM.

Front Hum Neurosci. 2012 Jun 21;6:184. doi: 10.3389/fnhum.2012.00184. eCollection 2012.

19.

Longitudinal progression of frontal and temporal lobe changes in schizophrenia.

Cobia DJ, Smith MJ, Wang L, Csernansky JG.

Schizophr Res. 2012 Aug;139(1-3):1-6. doi: 10.1016/j.schres.2012.05.002. Epub 2012 May 29.

20.

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE.

Schizophr Bull. 2013 Jan;39(1):120-9. doi: 10.1093/schbul/sbr069. Epub 2011 Jul 11. Review.

Supplemental Content

Support Center